Noninvasive test may predict retinopathy in type 1 diabetes patients

06/17/2011 | Irish Medical Times/Medical Publications Ltd.

Using noninvasive retinal testing to measure arteriolar length/diameter ratio and tortuosity may help predict retinopathy in patients with type 1 diabetes, a study in Diabetes Care suggests. Patients with the lowest LDRa and highest arterial tortuosity rates were at risk of developing diabetes-related retinopathy by up to 80% and 50% respectively, experts said.

View Full Article in:

Irish Medical Times/Medical Publications Ltd.

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN